Cargando…

Targets for astrocyte-based treatments of Parkinson’s disease (PD)

Detalles Bibliográficos
Autor principal:	Parmar, Malin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335267/ https://www.ncbi.nlm.nih.gov/pubmed/35858458 http://dx.doi.org/10.1073/pnas.2208876119

Ejemplares similares

Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
por: Barker, Roger A., et al.
Publicado: (2016)

The Potential Role of Astrocytes in Parkinson’s Disease (PD)
por: Hindeya Gebreyesus, Hiluf, et al.
Publicado: (2020)

Brainstem Evoked Potentials in the Idiopathic Parkinson's Disease (PD)
por: Vats, Ajay Kumar
Publicado: (2021)

New Targets and New Technologies in the Treatment of Parkinson’s Disease: A Narrative Review
por: Montemurro, Nicola, et al.
Publicado: (2022)

Astrocytes, Microglia, and Parkinson's Disease
por: Joe, Eun-Hye, et al.
Publicado: (2018)

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2016)

Astrocyte-based cell therapy: new hope for amyotrophic lateral sclerosis patients?
por: Barbeito, Luis
Publicado: (2018)

Metabolic alterations in Parkinson’s disease astrocytes
por: Sonninen, Tuuli-Maria, et al.
Publicado: (2020)

Neuron-Astrocyte Interactions in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2020)

Cell‐based therapy for Parkinson's disease: A journey through decades toward the light side of the Force
por: Parmar, Malin, et al.
Publicado: (2018)

Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment
por: Yu, Haiyang, et al.
Publicado: (2022)

Acupuncture for motor symptom improvement in Parkinson's disease and the potential identification of responders to acupuncture treatment
por: Leem, Jungtae
Publicado: (2016)

The Early Treatment Phase in Parkinson’s Disease: Not a Honeymoon for All, Not a Honeymoon at All?
por: Alonso-Canovas, Araceli, et al.
Publicado: (2023)

In SARS-CoV-2, astrocytes are in it for the long haul
por: Huang, Shuhan, et al.
Publicado: (2022)

Astrocytic TLR4 at the crossroads of inflammation and seizure susceptibility
por: Henneberger, Christian, et al.
Publicado: (2016)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Understanding of skeletal deformities in Parkinson's disease
por: Baik, Jong Sam
Publicado: (2016)

Immunotherapy trials in Parkinson’s disease: challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Self-Image in Women with Parkinson’s Disease
por: Mathur, Soania, et al.
Publicado: (2023)

LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease
por: Wang, Youcui, et al.
Publicado: (2021)

Revisiting the Role of Astrocytic MAOB in Parkinson’s Disease
por: Nam, Min-Ho, et al.
Publicado: (2022)

Role of Paeonol in an Astrocyte Model of Parkinson’s Disease
por: Ye, Maosheng, et al.
Publicado: (2017)

The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
por: Booth, Heather D.E., et al.
Publicado: (2017)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in preclinical models and the need to incorporate human modifying factors
por: Le, Catherine T., et al.
Publicado: (2019)

Cost and Return on Investment of a Team-Based Palliative Care Program for Parkinson Disease
por: McQueen, Robert Brett, et al.
Publicado: (2022)

Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease
por: Eyers, Patrick A.
Publicado: (2018)

A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
por: Tikhonova, Maria A.
Publicado: (2019)

Future of Monoclonal Antibody Therapy in Parkinson’s Disease
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Parkinson's disease in the elderly and the comprehensive geriatric assessment
por: Lauretani, Fulvio
Publicado: (2013)

Testing the Protein Propagation Hypothesis of Parkinson Disease
por: Dagher, Alain, et al.
Publicado: (2018)

Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
por: Noordegraaf, Marina A., et al.
Publicado: (2023)

Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson’s Disease
por: Chen, Kun, et al.
Publicado: (2023)

Waiting for PARIS—A Biological Target in Search of a Drug: PARIS farnesylation: Considerations in addressing a new biological target for neuroprotection in patients with Parkinson’s disease
por: Wyse, Richard K., et al.
Publicado: (2022)

The complex contribution of the astrocyte scar
por: Fitzgerald, Melinda
Publicado: (2016)

MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity
por: Lafourcade, Carlos, et al.
Publicado: (2016)

Divide et impera: How mitochondrial fission in astrocytes rules obesity
por: González-García, Ismael, et al.
Publicado: (2021)

Astrocytes for brain repair: More than just a neuron’s sidekick
por: Weber, Rebecca Z., et al.
Publicado: (2021)

The understanding of Parkinson's disease through genetics and new therapies
por: Uwishema, Olivier, et al.
Publicado: (2022)

Sex Differences in Parkinson’s Disease: From Bench to Bedside
por: Russillo, Maria Claudia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2htkii17o9csmpnjiq47dfeql